https://www.selleckchem.com/pr....oducts/cyclophospham
Kaplan-Meier analysis demonstrated significantly greater survival in patients less then 45 years of age (p = 0.0001). Survival to hospital discharge for those less then age 45 years was 84.6%. Comparatively, survival to hospital discharge for those ≥45 years was significantly lower (67.0%; p = 0.009), as was survival for those 55 years (57.1%; p = 0.001) and patients age ≥65 years (16.7%; p = 0.003). Patients 65 years of age and older treated with VV ECMO support for respiratory failure have low rates of survival to
Gefällt mir
Kommentar
Teilen
